Literature DB >> 33141298

Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.

Agnes-Sophie Fritz1, Titus Keller2, Angela Kribs2, Christoph Hünseler2.   

Abstract

The aim of our study was to observe the temporal distribution of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) in premature infants of ≤ 31 weeks of gestational age (GA) during the first weeks of life. NT-proBNP values of 118 preterm infants born ≤ 31 weeks GA were determined during the first week of life, after 4 ± 1 weeks of life, and at a corrected GA of 36 ± 2 weeks. Infants were divided into two groups: those without relevant complications and those with complications related to prematurity. NT-proBNP values of infants without complications define our exploratory reference values. The Median NT-proBNP level of these infants was 1896 ng/l (n = 27, interquartile range (IQR): 1277-5200) during the first week of life, 463 ng/l (n = 26, IQR: 364-704) at 4 ± 1 weeks of life, and 824 ng/l (n = 33, IQR: 714-1233) at a corrected GA of 36 ± 2 weeks. Infants born < 28 + 0 weeks GA had significantly higher NT-proBNP values (n = 9, median: 5200, IQR: 1750-8972) than infants born ≥ 28 + 0-31 weeks GA (n = 18, median: 1528, IQR: 838-3052; p = 0.017). Growth restriction or PDA status could not account for the difference in NT-proBNP values between GA groups.Conclusions: The results of our observational and cross-sectional study describe exploratory reference values for NT-proBNP levels in preterm infants of ≤ 31 weeks GA according to postnatal age. NT-proBNP levels during the first week of life are high and widely distributed in preterm infants and decrease subsequently to reach a distinctly lower and stable plateau at around 1 month of life. Our results suggest an influence of GA on NT-proBNP values in the first week of life. What is Known: • Several complications related to prematurity, e.g., hemodynamically significant PDA, pulmonary hypertension, bronchopulmonary dysplasia, and retinopathy of prematurity, have been associated with a temporary rise in NT-proBNP values in preterm infants during their first weeks of life. What is New: • This observational study provides reference values for NT-proBNP levels of very and extremely preterm infants during their first weeks of life. • In premature infants without complications, NT-proBNP values during their first week of life depend on gestational age at birth.

Entities:  

Keywords:  N-terminal pro-brain natriuretic peptide; Preterm infant; Reference values

Mesh:

Substances:

Year:  2020        PMID: 33141298      PMCID: PMC7940151          DOI: 10.1007/s00431-020-03853-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

Review 1.  Brain and other natriuretic peptides: molecular aspects.

Authors:  Marc Vanderheyden; Jozef Bartunek; Marc Goethals
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

2.  Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn.

Authors:  Alicia Montaner; Raquel Pinillos; Zenaida Galve; Hector Boix; Carmen Ruiz de la Cuesta; Lorenzo Jimenez; Pilar Samper; Segundo Rite
Journal:  Klin Padiatr       Date:  2017-07-17       Impact factor: 1.349

Review 3.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

4.  Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus.

Authors:  Vaneet K Kalra; Vincent A DeBari; Adel Zauk; Preetika Kataria; Dorothy Myridakis; Fuad Kiblawi
Journal:  Ann Clin Lab Sci       Date:  2011       Impact factor: 1.256

5.  Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.

Authors:  Johannes Buca Letshwiti; Jan Sirc; Ruth O'Kelly; Jan Miletin
Journal:  Eur J Pediatr       Date:  2014-06-05       Impact factor: 3.183

6.  NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.

Authors:  Paula Méndez-Abad; Pamela Zafra-Rodríguez; Simón Lubián-López; Isabel Benavente-Fernández
Journal:  Eur J Pediatr       Date:  2019-02-28       Impact factor: 3.183

7.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

8.  B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?

Authors:  Vaneet Kumar Kalra; Sanjeev Aggarwal; Prem Arora; Girija Natarajan
Journal:  Pediatr Pulmonol       Date:  2013-11-08

9.  N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

Authors:  Leon Joseph; Amiram Nir; Cathy Hammerman; Shmuel Goldberg; Efrat Ben Shalom; Elie Picard
Journal:  Am J Perinatol       Date:  2009-12-11       Impact factor: 1.862

10.  Natriuretic peptides in chronic kidney disease.

Authors:  Rajat Tagore; Lieng H Ling; Hong Yang; Hla-Yee Daw; Yiong-Huak Chan; Sunil K Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 8.237

View more
  2 in total

1.  Association Between NT-proBNP and Prolonged Length of Stay in Hospital Among Preterm Infants Born at 28-31 Weeks' Gestation.

Authors:  Jian Ge; Chenghan Luo; Mengyuan Lei; Zanyang Shi; Xinru Cheng; Min Zhao; Yanting Zhao; Min Song; Wenqian Ding; Mengmeng Wang; Wenjun Cao; Fengxia Mao; Suge Han; Qianya Xu; Junbo Wang; Haoqi Qin; Li Wang; Qian Zhang
Journal:  Front Pediatr       Date:  2022-01-24       Impact factor: 3.418

2.  Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?

Authors:  Ya-Lan Lin; Yi-Li Hung; Chung-Min Shen; Yung-Chuan Chen; Wu-Shiun Hsieh
Journal:  Children (Basel)       Date:  2022-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.